$500K Grant Supports Exploration of Therapies for Difficult-to-Treat Lymphomas
Daniel Herranz Benito, PhD, PharmD, resident researcher at Rutgers Cancer Institute of New Jersey, the state’s leading cancer program and only NCI-desig
Source: newswise.com